Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02431793 · ClinicalTrials.gov registry record · NA
EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use
A NA study of Opioid Use, Unspecified, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 652
- Enrollment target
- 1
- Study location
NCT02431793 is a NA study of Opioid Use, Unspecified that has completed, run by Northwestern University. The registered enrollment target is 652 participants, above the 155-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (321% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02431793, a NA study of Opioid Use, Unspecified, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 652 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effectiveness of an electronic health record based strategy in promoting safe use of opioid medications after an Emergency Department (ED) visit. The electronic health record (EHR)-based strategy was designed to enhance provider counseling about opioids and to standardize and simplify the information that patients receive.
Conditions Studied
Interventions
- BEHAVIORAL EMC2 Strategy
- BEHAVIORAL SMS Text Reminders
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 652 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02431793
The ClinicalTrials.gov registry entry for NCT02431793 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 652 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 155-participant average among 9 other Opioid Use, Unspecified trials with a reported enrollment target (321% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use, Unspecified appearing as the primary indexed condition, and to 2 interventions - of which EMC2 Strategy is the first listed.
NCT02431793 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02431793 about?
NCT02431793 is a clinical study titled "EHR-Based Medication Complete Communication Strategy to Promote Safe Opioid Use". The purpose of this study is to test the effectiveness of an electronic health record based strategy in promoting safe use of opioid medications after an Emergency Department (ED) visit. The electronic health record (EHR)-based strategy was designed to enhance provider counseling about opioids and t...
What is the current status of trial NCT02431793?
This trial is currently completed. It is a NA study. The enrollment target is 652 participants. The study started on 2015-07. Estimated completion is 2018-09.
What conditions does trial NCT02431793 study?
This clinical trial studies the following conditions: Opioid Use, Unspecified.
What interventions are being tested in trial NCT02431793?
The interventions under investigation include: EMC2 Strategy (BEHAVIORAL), SMS Text Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT02431793?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02431793 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use, Unspecified
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient Utilization of Opioid Destruction Bags in the Post-op Period
ACTIVE NOT RECRUITING · NA
-
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
COMPLETED · NA
-
Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase
COMPLETED · NA
-
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
COMPLETED · NA
-
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
RECRUITING
-
Sensory Outcomes in Active Substance Users
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.